Verana Health has enrolled the first subject in the Patient-Reported Outcomes for Minimally Invasive Glaucoma Surgery study, according to a press release.
The goal of the PRO-MIGS study is to develop the Glaucoma Outcomes Survey (GOS), a patient-reported outcome instrument that may be used for future FDA submissions of MIGS devices, the release said.
The FDA’s Center of Excellence in Regulatory Science and Innovation, the American Academy of Ophthalmology and the American Glaucoma Society are partners in the project.
“Recruiting and enrolling glaucoma patients at the ideal time
Uncategorized